These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 30780194

  • 21. A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial.
    Tai WC, Liang CM, Kuo CM, Huang PY, Wu CK, Yang SC, Kuo YH, Lin MT, Lee CH, Hsu CN, Wu KL, Hu TH, Chuah SK.
    J Antimicrob Chemother; 2019 Jun 01; 74(6):1718-1724. PubMed ID: 30768161
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori.
    Kekilli M, Onal IK, Ocal S, Dogan Z, Tanoglu A.
    Saudi J Gastroenterol; 2016 Jun 01; 22(5):366-369. PubMed ID: 27748322
    [Abstract] [Full Text] [Related]

  • 24. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
    Song Z, Zhou L, Zhang J, He L, Bai P, Xue Y.
    Dig Liver Dis; 2016 May 01; 48(5):506-511. PubMed ID: 26847964
    [Abstract] [Full Text] [Related]

  • 25. Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial.
    Pan J, Shi Z, Lin D, Yang N, Meng F, Lin L, Jin Z, Zhou Q, Wu J, Zhang J, Li Y.
    Front Med; 2020 Feb 01; 14(1):43-50. PubMed ID: 31907860
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
    Fiorini G, Zullo A, Saracino IM, Gatta L, Pavoni M, Vaira D.
    Eur J Gastroenterol Hepatol; 2018 Jun 01; 30(6):621-625. PubMed ID: 29481383
    [Abstract] [Full Text] [Related]

  • 28. Comparison Between Sequential Therapy and Modified Bismuth-Included Quadruple Therapy for Helicobacter pylori Eradication in Chinese Patients.
    Yang X, Tan P, Song L, Lu Z.
    Am J Ther; 2016 Jun 01; 23(6):e1436-e1441. PubMed ID: 25923229
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study.
    Ciccaglione AF, Cellini L, Grossi L, Manzoli L, Marzio L.
    Helicobacter; 2015 Oct 01; 20(5):390-6. PubMed ID: 25801708
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.
    Liang X, Xu X, Zheng Q, Zhang W, Sun Q, Liu W, Xiao S, Lu H.
    Clin Gastroenterol Hepatol; 2013 Jul 01; 11(7):802-7.e1. PubMed ID: 23376004
    [Abstract] [Full Text] [Related]

  • 32. Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label study.
    Yi DM, Yang TT, Chao SH, Li YX, Zhou YL, Zhang HH, Lan L, Zhang YW, Wang XM, Zhang YR, Li J, Ding SZ.
    Medicine (Baltimore); 2019 Feb 01; 98(6):e14408. PubMed ID: 30732192
    [Abstract] [Full Text] [Related]

  • 33. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.
    Sezgin O, Aydın MK, Özdemir AA, Kanık AE.
    Turk J Gastroenterol; 2019 May 01; 30(5):420-435. PubMed ID: 31060997
    [Abstract] [Full Text] [Related]

  • 34. Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial.
    He XJ, Wang XL, Huang XY, Li DZ, Liu G, Wang W, Li DL.
    Clin Res Hepatol Gastroenterol; 2023 Jan 01; 47(1):102052. PubMed ID: 36400418
    [Abstract] [Full Text] [Related]

  • 35. Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication.
    Gao XZ, Qiao XL, Song WC, Wang XF, Liu F.
    World J Gastroenterol; 2010 Sep 14; 16(34):4357-62. PubMed ID: 20818821
    [Abstract] [Full Text] [Related]

  • 36. Comparison of high-dose dual therapy with bismuth-containing quadruple therapy in Helicobacter pylori-infected treatment-naive patients: An open-label, multicenter, randomized controlled trial.
    Guan JL, Hu YL, An P, He Q, Long H, Zhou L, Chen ZF, Xiong JG, Wu SS, Ding XW, Luo HS, Li PY.
    Pharmacotherapy; 2022 Mar 14; 42(3):224-232. PubMed ID: 35075679
    [Abstract] [Full Text] [Related]

  • 37. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
    Lee JY, Kim N, Park KS, Kim HJ, Park SM, Baik GH, Shim KN, Oh JH, Choi SC, Kim SE, Kim WH, Park SY, Kim GH, Lee BE, Jo Y, Hong SJ.
    BMC Gastroenterol; 2016 Jul 26; 16(1):79. PubMed ID: 27460100
    [Abstract] [Full Text] [Related]

  • 38. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
    Georgopoulos SD, Xirouchakis E, Martinez-Gonzales B, Zampeli E, Grivas E, Spiliadi C, Sotiropoulou M, Petraki K, Zografos K, Laoudi F, Sgouras D, Mentis A, Kasapidis P, Michopoulos S.
    Eur J Intern Med; 2016 Jul 26; 32():84-90. PubMed ID: 27134145
    [Abstract] [Full Text] [Related]

  • 39. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.
    J Dig Dis; 2007 Nov 26; 8(4):211-5. PubMed ID: 17970879
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.